Sugi Predict

Sugi Predict / Compounds / SCHEMBL10113384

SCHEMBL10113384

SCHEMBL10113384

CC(C)(C)S(=O)(=O)NC1CCC(C(=O)Nc2nnc(-c3ccc(F)cc3)s2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 2/20 0.54
▸ CSNK2A1 P68400 2/20 0.54
▸ NPY5R Q15761 1/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ LMNA P02545 1/20 0.44
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ PSMD14 O00487 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13203876 1.00 CSNK2A2 (0.54) CSNK2A2CSNK2A1NPY5RSMN1; SMN2KMT2A
SCHEMBL10114426 0.89 CSNK2A2 (0.56) CSNK2A2CSNK2A1NPY5RSMN1; SMN2KMT2A
SCHEMBL10133429 0.89 CSNK2A2 (0.56) CSNK2A2CSNK2A1NPY5RSMN1; SMN2KMT2A
SCHEMBL14424631 0.85 CSNK2A2 (0.54) CSNK2A2CSNK2A1SMN1; SMN2KMT2AMEN1
SCHEMBL10114864 0.85 CSNK2A2 (0.54) CSNK2A2CSNK2A1SMN1; SMN2KMT2AMEN1
SCHEMBL10115651 0.85 SMN1; SMN2 (0.45) CSNK2A2CSNK2A1NPY5RSMN1; SMN2KMT2A
SCHEMBL13564957 0.81 NPY5R (0.42) CSNK2A2CSNK2A1NPY5RSMN1; SMN2KMT2A
SCHEMBL17090502 0.81 NPY5R (0.42) CSNK2A2CSNK2A1NPY5RSMN1; SMN2KMT2A
SCHEMBL10113061 0.81 NPY5R (0.58) NPY5RSMN1; SMN2KMT2AMEN1LMNA
SCHEMBL12864673 0.81 NPY5R (0.58) NPY5RSMN1; SMN2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R CSNK2A2 223/4885CSNK2A1 218/4885NPY5R 1/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R CSNK2A2 155/4885CSNK2A1 148/4885NPY5R 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.